Editorial: Pharmacological Therapy to Prevent Sudden Cardiac Death: Indications and Limitations in the Era of Devices

2018 ◽  
Vol 18 (6) ◽  
pp. 466-467
Author(s):  
Pier Paolo Bassareo ◽  
Mercuro Giuseppe
2020 ◽  
Vol 71 (11-12) ◽  
pp. 286-292
Author(s):  
M Burtscher ◽  
D Niederseer

Sudden cardiac death (SCD) is an unanticipated and dramatic event resulting from cardiac causes. First reports on SCDs during mountain sports activities date back to the 1970s and 1980s of the last century. Relatively large datasets have been collected in Austria from 1985 onwards initiating systematic recordings and analyses of risk factors and triggers of SCDs during mountain sports activities. The results presented in this publication are derived from a literature search on reported SCDs that occurred during selected mountaineering activities with particular regard to study findings based on data collected in Austria. We found a relatively low SCD risk during mountaineering activities, amounting to about 1 SCD per 1 million activity days when hiking, trekking or ski touring, which is even lower during downhill skiing but higher in competitive cross-country skiing. The risk is much higher in men than in women and increases sharply above the age of 34. Main risk factors include prior myocardial infarction, coronary artery disease, arterial hypertension, hypercholesterolaemia and diabetes mellitus type 2, but regular and sport-specific activities turned out to be important protective factors. Unaccustomed physical exertion, in particular on the first days in the mountains (altitude), prolonged activities without rest and insufficient energy and fluid intake represent important SCD triggers. Besides considering these potential triggers during mountaineering activities, sports medical examination, appropriate pharmacological therapy of risk factors and physical preparation represent preventive key elements. Key Words: Exercise, Mountains, Cardiovascular, Risk, Triggers, Prevention


2017 ◽  
Vol 27 (S1) ◽  
pp. S57-S61 ◽  
Author(s):  
Gabriela M. Orgeron ◽  
Jane E. Crosson

AbstractArrhythmogenic right ventricular dysplasia/cardiomyopathy is an inherited cardiomyopathy characterised by ventricular arrhythmias and an increased risk of sudden cardiac death. Arrhythmogenic right ventricular dysplasia/cardiomyopathy diagnosis is based on criteria that take into account electrical and structural cardiac abnormalities, as well as mutation analysis. Appropriate pharmacological therapy and the prevention of sudden death with implantable defibrillators are important in the management of these patients. Exercise is considered an important environmental factor for the development and progression of the disease.


ESC CardioMed ◽  
2018 ◽  
pp. 2270-2275
Author(s):  
Akihiko Nogami

Bundle branch reentry ventricular tachycardia, a unique form of reentrant ventricular tachycardia involving the His–Purkinje system, occurs in patients with cardiomyopathy and His–Purkinje conduction disease. It responds poorly to pharmacological therapy and can be cured effectively with catheter ablation. However, even after ablation, patients may remain at risk for total mortality and sudden cardiac death and may require further therapies including cardiac resynchronization therapy defibrillators.


2008 ◽  
Vol 7 ◽  
pp. 109-109
Author(s):  
R BRECKENRIDGE ◽  
Z ZUBERI ◽  
L FELKIN ◽  
E BIRKS ◽  
P BARTON ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document